ਖੋਜ (ਖ਼ਬਰਾਂ)

Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed With U.S. Food And Drug Administration (FDA) For Tabelecleucel Biologic License Application (BLA)

top health

(MENAFN - PR Newswire)SECAUCUS, N.J., March 12, 2026 /PRNewswire/ -- Pierre Fabre Pharmaceuticals, Inc., announces the U.S. Food and Drug Administration (FDA) has agreed to Type A meeting for the ...
2026-03-12 08:01:57